Anchor Investment Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244 | Hold |
30
| – | – | ﹤0.01% | 1026 |
|
|
2025
Q1 | $236 | Hold |
30
| – | – | ﹤0.01% | 1022 |
|
|
2024
Q4 | $447 | Hold |
30
| – | – | ﹤0.01% | 999 |
|
|
2024
Q3 | $459 | Hold |
30
| – | – | ﹤0.01% | 1020 |
|
|
2024
Q2 | $457 | Hold |
30
| – | – | ﹤0.01% | 972 |
|
|
2024
Q1 | $566 | Hold |
30
| – | – | ﹤0.01% | 1007 |
|
|
2023
Q4 | $573 | Hold |
30
| – | – | ﹤0.01% | 931 |
|
|
2023
Q3 | $539 | Hold |
30
| – | – | ﹤0.01% | 947 |
|
|
2023
Q2 | $609 | Hold |
30
| – | – | ﹤0.01% | 935 |
|
|
2023
Q1 | $547 | Hold |
30
| – | – | ﹤0.01% | 964 |
|
|
2022
Q4 | $620 | Hold |
30
| – | – | ﹤0.01% | 931 |
|
|
2022
Q3 | $785 | Hold |
30
| – | – | ﹤0.01% | 945 |
|
|
2022
Q2 | $760 | Hold |
30
| – | – | ﹤0.01% | 945 |
|
|
2022
Q1 | $947 | Buy |
+30
| New | +$947 | ﹤0.01% | 959 |
|